Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FENC
DateTimeSourceHeadlineSymbolCompany
14/05/202422:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
14/05/202411:03GlobeNewswire Inc.Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
13/05/202421:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FENCFennec Pharmaceuticals Inc
07/05/202423:15GlobeNewswire Inc.Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
21/03/202410:00GlobeNewswire Inc.Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
19/03/202410:01GlobeNewswire Inc.Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024NASDAQ:FENCFennec Pharmaceuticals Inc
18/03/202407:00PR Newswire (US)Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
18/03/202401:00GlobeNewswire Inc.Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New ZealandNASDAQ:FENCFennec Pharmaceuticals Inc
06/03/202421:07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FENCFennec Pharmaceuticals Inc
29/02/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FENCFennec Pharmaceuticals Inc
29/02/202412:04GlobeNewswire Inc.Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsNASDAQ:FENCFennec Pharmaceuticals Inc
14/02/202415:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FENCFennec Pharmaceuticals Inc
01/02/202410:55GlobeNewswire Inc.FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving CisplatinNASDAQ:FENCFennec Pharmaceuticals Inc
05/01/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
05/01/202421:45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
04/01/202421:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
29/12/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
28/12/202320:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
18/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FENCFennec Pharmaceuticals Inc
05/12/202310:55GlobeNewswire Inc.Fennec Announces Incremental $5 Million Investment from PetrichorNASDAQ:FENCFennec Pharmaceuticals Inc
16/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202321:56Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202321:52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202321:50GlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
09/11/202321:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
08/11/202323:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
06/11/202310:59GlobeNewswire Inc.Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:FENCFennec Pharmaceuticals Inc
03/11/202321:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FENCFennec Pharmaceuticals Inc
30/10/202310:45GlobeNewswire Inc.Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:FENCFennec Pharmaceuticals Inc
07/09/202310:59GlobeNewswire Inc.Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:FENCFennec Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:FENC